During the past decade, Hospital Universitario de Burgos conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 10 clinical trials were completed, i.e. on average, 10.4% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 7 clinical trials were completed. i.e. 15.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Burgos" #1 sponsor was "PETHEMA Foundation" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Spanish Breast Cancer Research Group" with 4 trials sponsored and "Spanish Oncology Genito-Urinary Group" with 4 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Burgos" #1 collaborator was "Celgene" with 3 trials as a collaborator, "Dynamic Science S.L." with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud" with 2 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Burgos" are "Breast Cancer" (6 trials), "Multiple Myeloma" (6 trials), "Advanced Prostate Cancer" (3 trials), "Atrial Fibrillation" (3 trials) and "Neuroendocrine Tumors" (3 trials). Many other conditions were trialed in "Hospital Universitario de Burgos" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Burgos" are "Drug" (53 trials), "Other" (14 trials), "Device" (9 trials), "Biological" (8 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Cyclophosphamide" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Burgos" are 100 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Burgos". 1 are not yet recruiting, 24 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Hospital Universitario de Burgos, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Burgos, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".

Hospital Universitario de Burgos has several departments that took part in Clinical trials: "Complejo Asistencial Universitario De Burgos; Servicio de Oncologia" - 7 trials